Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M L Lippmann

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
The American Journal of Medicine|May 1, 1987
Aminophylline allergyA Saven, M L Lippmann
Lung|January 1, 1996
Susceptibility to amiodarone-induced pulmonary toxicity: relationship to the uptake of amiodarone by isolated lung cellsB D Wilson, M L Lippmann
The American Review of Respiratory Disease|June 1, 1990
Pulmonary accumulation of amiodarone and N-desethylamiodarone. Relationship to the development of pulmonary toxicityB D Wilson, M L Lippmann
American Journal of Respiratory Cell and Molecular Biology|September 1, 1993
Amiodarone pulmonary toxicity in the rat is associated with increased lavage immunoglobulin and alveolar macrophages primed for increased interleukin-1 secretionB D Wilson, M L Lippmann
Chest|September 1, 1993
Diagnosis of acute pulmonary embolism in patients with COPDM L Lippmann, A M Fein
The American Journal of Medicine|October 1, 1984
Endobronchial lymphocytic infiltration. Unusual manifestation of chronic lymphocytic leukemiaA Chernoff, J Rymuza, M L Lippmann
Chest|December 1, 1990
Bronchoscopy in hemoptysisM L Lippmann, M D Walkenstein, S K Goldberg
The American Review of Respiratory Disease|May 1, 1991
Amiodarone-induced pulmonary inflammation. Correlation with drug dose and lung levels of drug, metabolite, and phospholipidB D Wilson, C E Clarkson, M L Lippmann
Lung|January 1, 1993
Amiodarone causes decreased cell-mediated immune responses and inhibits the phospholipase C signaling pathwayB D Wilson, C E Clarkson, M L Lippmann
Critical Care Medicine|November 1, 1982
Clinical pulmonary embolism from migration of a retained transvenous permanent pacemaker electrodeG S Drizin, A M Fein, M L Lippmann
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
The American Journal of Medicine|May 1, 1987
Aminophylline allergyA Saven, M L Lippmann
Lung|January 1, 1996
Susceptibility to amiodarone-induced pulmonary toxicity: relationship to the uptake of amiodarone by isolated lung cellsB D Wilson, M L Lippmann
The American Review of Respiratory Disease|June 1, 1990
Pulmonary accumulation of amiodarone and N-desethylamiodarone. Relationship to the development of pulmonary toxicityB D Wilson, M L Lippmann
American Journal of Respiratory Cell and Molecular Biology|September 1, 1993
Amiodarone pulmonary toxicity in the rat is associated with increased lavage immunoglobulin and alveolar macrophages primed for increased interleukin-1 secretionB D Wilson, M L Lippmann
Chest|September 1, 1993
Diagnosis of acute pulmonary embolism in patients with COPDM L Lippmann, A M Fein
The American Journal of Medicine|October 1, 1984
Endobronchial lymphocytic infiltration. Unusual manifestation of chronic lymphocytic leukemiaA Chernoff, J Rymuza, M L Lippmann
Chest|December 1, 1990
Bronchoscopy in hemoptysisM L Lippmann, M D Walkenstein, S K Goldberg
The American Review of Respiratory Disease|May 1, 1991
Amiodarone-induced pulmonary inflammation. Correlation with drug dose and lung levels of drug, metabolite, and phospholipidB D Wilson, C E Clarkson, M L Lippmann
Lung|January 1, 1993
Amiodarone causes decreased cell-mediated immune responses and inhibits the phospholipase C signaling pathwayB D Wilson, C E Clarkson, M L Lippmann
Critical Care Medicine|November 1, 1982
Clinical pulmonary embolism from migration of a retained transvenous permanent pacemaker electrodeG S Drizin, A M Fein, M L Lippmann
Pageof 3